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Figure 1. Obesity prevalence (%) worldwide 2008 (adapted from WHO)  































Figure 2. Diabetes prevalence (%) worldwide 2013 (adapted from IDF)  
Obesity 
The increasing global burden of obesity has become a major public health problem. Prevalence of obesity has 
been increasing in the world and now, worldwide obesity has exceed 285 million.    
Obesity is defined as abnormal or excessive fat accumulation that results in health risk. A common measure of 
obesity is the body mass index (BMI). A person with a BMI of 30 or more is generally considered obese.  
In addition, this disease is a major risk factor for serious chronic diseases including diabetes, cardiovascular 
diseases and some types of cancer. However, the mechanisms whereby obesity leads to these metabolic 
complications are not fully understood.  
The association of obesity with type 2 diabetes has been recognized for decades, and the major basis for this link 
is the ability of obesity to engender insulin resistance. Although many details of the mechanisms by which the 
enlarged adipose tissue mass that defines obesity causes systemic insulin resistance remain unknown.  
Adipose Tissue 
Figure 3. Scanning EM image from 
WAT (Cinti S, 2012) 
Figure 4. Scanning EM image from 
BAT (Cinti S, 2012) 
During obesity there is an expansion of adipose 
tissue mass due to:  
 
• Hypertrophy: adipocyte enlargement  
• Hyperplasia: increased number of 
adipocytes  
There are two types of adipose tissue: 
white adipose tissue (WAT) and brown 
adipose tissue (BAT).  
It is easy to distinguish the adipocytes 
by their morphology:  
• White adipocytes have ≈90% 
comprised by a lipid droplet and a 
“squeezed” nucleus.  
• Brown adipocytes have several lipid 
droplets, a roundish nucleus and 
many mitochondria. .  
WAT’s function is to store 
excess energy in the form of 
TGs. In contrast, BAT oxidizes 
fuels and dissipates energy in 
the form of heat. Both 
secrete cytokines. 
Figure 5. Functions of white and brown 
adipocytes (Cinti S, 2012) 
 
WAT is distributed throughout the 
body and there are two types:  
•  vWAT or visceral 
• sWAT or subcutaneous 
Accumulation of vWAT (apple 
shape) has higher risk of weight-
related health problems than 
sWAT (pear shape).  
 Figure 6. Different body fat distribution leads to “apple” and “pear” 
shape (adapted from fitneAss) 
The three Hs 
The adipose tissue is highly vascularized and during obesity 
development, there is a fat mass expansion associated with 
angiogenesis.  
However, this enlargement of the vascular network is not 
sufficient to supply enough oxygen to all adipocytes and 
local hypoxia occurs.  
This hypoxia may induce adipocyte death and macrophages 
recruitment, which in turn can secrete pro-inflammatory 
signals and trigger systemic insulin resistance. 
Figure 7. Inflammation and hypoxia in obese and normal tissue (adapted from Neels et al, 2006)  
Adipose tissue hypoxia (ATH) represents a novel 
causative risk factor for the chronic 
inflammation in obesity. Hypoxia induces 
inflammation through activation of HIF-1α and 
NF-kB, each of which activates transcription of 
several angiogenic and/or pro-inflammatory 
cytokines.  
 
This process also provides a mechanism for the 
pathological responses in adipose tissue, such as 
ER stress, oxidative stress, adipocyte death, 
adiponectin reduction and leptin induction.  
Figure 8. Hypoxia as a common root for various changes in adipose tissue in 
obesity (Ye J, 2013) 































The obese adipose tissue, and particularly visceral fat, is infiltrated with macrophages, which form Crown-like 
structures (CLSs) surrounding death and dying adipocytes. These macrophages produce pro-inflammatory 
cytokines that enter the systemic circulation and contribute to the development of insulin resistance.   
Some of this cytokines like TNFα, IL6 and IL1β have been reported to impair insulin signaling.   
Figure 9. Infiltration of macrophages forming Crown-like structures. (Cinti S, 2013)  Figure 10. Macrophages surrounding a dying adipocyte 
(Cinti S, 2013)  
Figure 11. Changes of immune cells populations in adipose tissue in obesity (Feng B et al, 2013)  
 Adipose tissue macrophages 
(ATMs) play an important role in 
the establishment of the chronic 
inflammatory state associated 
with obesity and its metabolic 
dysfunctions.  
ATM from lean individuals are M2  
macrophages (anti-inflammatory 
properties), whereas ATMs from 
obese individuals are 
predominantly M1 (pro-
inflammatory).  
Therapies for Type 2 Diabetes Conclusion 
On the basis of the current data, the sequence 
of events linking obesity with insulin resistance 
could be:  
 
•  Adipocyte hypertrophy due to obesity 
•  Adipocyte stress, possibly involving hypoxia 
and the production of chemo attractants 
•  Chemo attraction and infiltration of 
macrophages 
• Death of adipocytes  
•  Chronic reabsorption of adipocyte remnants 
by macrophages and massive production of 
cytokines 
•  Increased levels of circulations cytokines 
contributes to insulin resistance in peripheral 
tissues 
Figure 12. Impact of pro-inflammation and anti-inflammation events in adipose 
tissue on glucose homeostasis in peripheral tissues (Ye J, 2013) 
 Leptin 
Leptin is an adipose secreted cytokine and plays an important role in satiety, food intake and energy 
expenditure. It’s an important negative regulator of weight and it has been described as a potential molecule 
to target on obesity therapy. However, it has been reported a tiny loss-weight due to this therapy.  
 Adiponectin 
Adiponectin exerts insulin sensitivity, is anti-inflammatory and anti-apoptotic. In obese adipose tissue its 
secretion and activity is decreased. This molecule acts in the brain, increasing the energy expenditure and 
causing weight loss.  In some studies, the administration of a recombinant adiponectin improved insulin 
sensitivity in the liver, increased insulin secretion and obtained beneficial effects on body weight and 
hyperglycemia.  
Recently Okada-Iwabu have produced a synthetic small molecule that is an agonist receptor of adiponectin 
(AdipoRon), with really good results, making adiponectin and their agonist receptors some promising 
candidates for therapy.  
 VEGF-A 
Vascular endothelial growth factor A is a key molecule in vasculogenesis and angiogenesis. Recent evidence 
suggest a potential role of this growth factor in the control of energy metabolism: VEGF-A overexpression 
protects against diet-induced obesity and insulin resistance. The overexpression leads to an increase in BAT 
thermogenesis and also promotes a “BAT-like” phenotype in WAT depots. In addition, VEGF-A has anti-
inflammatory properties with a chemotactic activity specific for M2 macrophages.  
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